Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

TIL

Instill Bio (TIL)

Instill Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TIL
DateTimeSourceHeadlineSymbolCompany
12:49PMiHub NewswireFeaturedCannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California
03/21/20245:00PMGlobeNewswire Inc.Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
02/14/20244:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
02/13/20245:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TILInstill Bio Inc
01/18/20247:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
01/16/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
01/16/20248:00AMGlobeNewswire Inc.Instil Bio Announces Strategic UpdateNASDAQ:TILInstill Bio Inc
01/10/20248:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TILInstill Bio Inc
01/10/20247:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TILInstill Bio Inc
12/08/20235:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
12/05/20235:00PMGlobeNewswire Inc.Instil Bio Announces Effective Date of 1-for-20 Reverse Stock SplitNASDAQ:TILInstill Bio Inc
11/27/20237:13AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
11/13/20235:27PMEdgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:TILInstill Bio Inc
11/13/20235:03PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TILInstill Bio Inc
11/13/20235:00PMGlobeNewswire Inc.Instil Bio Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
11/13/20235:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
11/06/20237:00AMGlobeNewswire Inc.Instil Bio Announces Poster Presentations of ITIL-306 Preclinical Data at SITC 2023 Annual MeetingNASDAQ:TILInstill Bio Inc
08/14/20237:05AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TILInstill Bio Inc
08/14/20237:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
08/14/20237:00AMGlobeNewswire Inc.Instil Bio Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
06/26/20234:38PMGlobeNewswire Inc.Instil Bio Announces Oral Presentation of ITIL-306 Preclinical Data at British Society for Gene and Cell Therapy Annual ConferenceNASDAQ:TILInstill Bio Inc
06/26/20234:33PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TILInstill Bio Inc
06/14/20234:32PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TILInstill Bio Inc
05/11/20237:06AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TILInstill Bio Inc
05/11/20237:00AMGlobeNewswire Inc.Instil Bio Reports First Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
04/28/20234:37PMEdgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:TILInstill Bio Inc
04/24/20234:31PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TILInstill Bio Inc
04/10/20239:38AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TILInstill Bio Inc
03/31/20237:40AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:TILInstill Bio Inc
03/31/20237:08AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TILInstill Bio Inc
 Showing the most relevant articles for your search:NASDAQ:TIL